docetaxel anhydrous has been researched along with Cancer of the Tongue in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (40.00) | 29.6817 |
2010's | 5 (33.33) | 24.3611 |
2020's | 4 (26.67) | 2.80 |
Authors | Studies |
---|---|
Chang, KC; Chang, KY; Chen, YW; Fang, KM; Lee, KI; Lin, JW; Liu, JM; Liu, SH; Su, CC; Wu, CT | 1 |
Chen, X; Hata, M; Hayashi, Y; Kioi, M; Koike, I; Koizumi, T; Mitsudo, K; Yamanaka, S | 1 |
Ahn, MJ; Ahn, YC; Baek, CH; Chung, MK; Hong, J; Jeong, HS; Lim, SH; Oh, D; Park, K; Son, YI; Sun, JM | 1 |
Cui, J; Ma, J; Sun, X; Wang, H; Zhang, J; Zhang, X | 1 |
Huang, H; Huang, X; Li, X; Liu, Y; Wang, H; Yu, M; Zhang, J; Zhang, Y | 1 |
Chikamatsu, K; Ishioka, NS; Kaira, K; Kanai, Y; Nagamori, S; Ohshima, Y; Oriuchi, N; Oyama, T; Sakakura, K; Shino, M; Takahashi, K; Takayasu, Y; Tominaga, H; Toyoda, M | 1 |
Fietkau, R; Iro, H; Klautke, G; Kuwert, T; Lell, M; Linke, R; Semrau, S; Uder, M; Waldfahrer, F | 1 |
Koroleva, IA; Mochalova, AS | 1 |
Asakawa, T; Furusaka, T; Ikeda, M; Matsuda, H; Tanaka, A | 1 |
Bayouth, J; Culp, LR; Jones, DV; Pou, AM; Sanguineti, G | 1 |
Komori, T; Shibuya, Y; Tanimoto, H; Umeda, M; Yokoo, S | 1 |
Endo, S; Himi, K; Kida, A; Niwa, H; Noguchi, Y; Suzuki, S; Takemoto, A; Tanaka, Y; Tsuji, K; Yoshida, K | 1 |
Tohnai, I | 1 |
Furusaka, T | 1 |
Furutani, M; Kokubo, M; Nagano, M; Ohnishi, M; Takenobu, T; Tanaka, Y; Taniike, N | 1 |
1 review(s) available for docetaxel anhydrous and Cancer of the Tongue
Article | Year |
---|---|
Chemotherapy using intra-arterial infusion for oral cancer.
Topics: Antineoplastic Agents; Cisplatin; Docetaxel; Femoral Artery; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mouth Neoplasms; Taxoids; Temporal Arteries; Tongue Neoplasms | 2006 |
2 trial(s) available for docetaxel anhydrous and Cancer of the Tongue
Article | Year |
---|---|
Induction chemotherapy followed by concurrent chemoradiotherapy versus CCRT for locally advanced hypopharynx and base of tongue cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Hypopharynx; Induction Chemotherapy; Tongue Neoplasms | 2021 |
Rescue of iCIKs transfer from PD-1/PD-L1 immune inhibition in patients with resectable tongue squamous cell carcinoma (TSCC).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Transplantation; Cells, Cultured; Cisplatin; Cytokines; Docetaxel; Female; Fluorouracil; Humans; Killer Cells, Natural; Male; Middle Aged; Programmed Cell Death 1 Receptor; Taxoids; Tongue Neoplasms | 2018 |
12 other study(ies) available for docetaxel anhydrous and Cancer of the Tongue
Article | Year |
---|---|
Involvement of AMPKα and MAPK-ERK/-JNK Signals in Docetaxel-Induced Human Tongue Squamous Cell Carcinoma Cell Apoptosis.
Topics: AMP-Activated Protein Kinases; Apoptosis; Carcinoma, Squamous Cell; Caspase 3; Docetaxel; Epithelial Cells; Extracellular Signal-Regulated MAP Kinases; Humans; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Tongue; Tongue Neoplasms | 2022 |
Efficacy of concurrent chemoradiotherapy with retrograde super selective intra-arterial infusion combined with cetuximab for synchronous multifocal oral squamous cell carcinomas.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cetuximab; Chemoradiotherapy; Cisplatin; Docetaxel; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Male; Mouth Neoplasms; Squamous Cell Carcinoma of Head and Neck; Taxoids; Tongue Neoplasms | 2023 |
Exosomal miR-200c suppresses chemoresistance of docetaxel in tongue squamous cell carcinoma by suppressing TUBB3 and PPP2R1B.
Topics: Animals; Cell Line, Tumor; Docetaxel; Drug Resistance, Neoplasm; Exosomes; Humans; Male; Mice; Mice, Inbred BALB C; MicroRNAs; Protein Phosphatase 2; RNA-Seq; Squamous Cell Carcinoma of Head and Neck; Tongue Neoplasms; Tubulin | 2020 |
Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Transport System ASC; Amino Acid Transport System y+; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease-Free Survival; Docetaxel; Drug Combinations; Female; Fusion Regulatory Protein 1, Heavy Chain; Humans; Kaplan-Meier Estimate; Ki-67 Antigen; Large Neutral Amino Acid-Transporter 1; Lymphatic Metastasis; Male; Middle Aged; Minor Histocompatibility Antigens; Neoplasm Proteins; Neoplasm Staging; Oxonic Acid; Prognosis; Taxoids; Tegafur; Tongue Neoplasms; Treatment Outcome; Tumor Suppressor Protein p53 | 2014 |
Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. Early r
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Disease Progression; Docetaxel; Feasibility Studies; Female; Follow-Up Studies; Humans; Hypopharyngeal Neoplasms; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Kaplan-Meier Estimate; Laryngeal Neoplasms; Leukopenia; Lymphatic Metastasis; Male; Neoadjuvant Therapy; Neoplasm Staging; Opportunistic Infections; Paclitaxel; Positron-Emission Tomography; Radiodermatitis; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Salvage Therapy; Taxoids; Thrombocytopenia; Tomography, X-Ray Computed; Tongue Neoplasms; Treatment Outcome | 2011 |
[Support of hematological homeostasis during chemotherapy with taxanes].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Caproates; Docetaxel; Female; Fever; Follow-Up Studies; Homeostasis; Humans; Imidazoles; Lung Neoplasms; Male; Middle Aged; Neoplasms; Neutropenia; Ovarian Neoplasms; Paclitaxel; Prostatic Neoplasms; Protective Agents; Severity of Illness Index; Stomach Neoplasms; Taxoids; Tongue Neoplasms | 2011 |
Efficacy of multidrug superselective intra-arterial chemotherapy (docetaxel, cisplatin, and 5-fluorouracil) using the Seldinger technique for tongue cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Cohort Studies; Disease-Free Survival; Docetaxel; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Head and Neck Neoplasms; Humans; Infusions, Intra-Arterial; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prospective Studies; Radiotherapy, Adjuvant; Risk Assessment; Salvage Therapy; Survival Analysis; Taxoids; Tongue; Tongue Neoplasms; Treatment Outcome | 2012 |
A case of radiation recall mucositis associated with docetaxel.
Topics: Antineoplastic Agents, Phytogenic; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Docetaxel; Humans; Inflammation; Male; Middle Aged; Mucous Membrane; Neoplasm Recurrence, Local; Radiation-Sensitizing Agents; Radiodermatitis; Radiotherapy, Adjuvant; Taxoids; Tongue Neoplasms | 2004 |
Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil for tongue cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Female; Fluorouracil; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Remission Induction; Taxoids; Tongue Neoplasms | 2004 |
[Intraarterial concomitant chemoradiation for tongue cancer: analysis of 20 patients].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Prognosis; Retrospective Studies; Taxoids; Thiosulfates; Tongue Neoplasms | 2005 |
[Superselective intra-arterial infusion therapy with docetaxel, cisplatin and 5-fluorouracil for head and neck cancer--for tongue cancer patients in comparison patients with other therapies].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Docetaxel; Drug Administration Schedule; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Hydrocortisone; Infusions, Intra-Arterial; Male; Middle Aged; Remission Induction; Survival Rate; Taxoids; Tongue Neoplasms | 2006 |
[A case of metastatic lung cancer responding well from tongue carcinoma using a combination of stereotactic radiation therapy and docetaxel/cisplatin/5-FU chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Drug Administration Schedule; Fluorouracil; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Radiotherapy Dosage; Remission Induction; Taxoids; Tongue Neoplasms | 2006 |